More than 7 million children are born after assisted reproductive technology (ART). Between 2 and 6% of the European birth cohort is conceived by ART. The marked reduction in ART multiple birth rates has significantly improved perinatal outcomes in children conceived by ART. The risk of preterm birth and low birthweight is slightly increased in singletons after standard in vitro fertilisation (IVF), whereas oocyte donation yields between a two-and three-fold increased risk of pre-eclampsia. Neurodevelopmental health and school performance in children conceived by ART and spontaneously conceived children are similar. There is no increased risk of cancer in both childhood and adulthood after ART conception. There may be altered cardiometabolic health risks in children conceived by ART, but this needs further investigation.
Trends over time in assisted reproductive technology
It has been 40 years since Louise Brown, the first child born after in vitro fertilisation, was born in 1978, and now more than 7 million children are conceived with assisted reproductive technology (ART). There has been a tremendous increase in the number of ART cycles, and several more advanced treatments have been developed, such as intracytoplasmic sperm injection (ICSI).
1,2 ICSI has revolutionised the treatment of severe male factor infertility after the first ICSI baby was born in 1992. 3 More recently, vitrification, the ultrafast method of oocyte and embryo freezing, has changed treatment strategies towards greater use of freezing and thawing, as the survival rate of the frozen embryos has risen dramatically. Pre-implantation genetic testing for aneuploidies (PGT-a) is the most recent technique that has been implemented. With the limited safety assessments of the trophectoderm biopsy, however, there is a risk of discarding healthy embryos as a result of mosaicism. Furthermore, ovarian stimulation has shifted towards milder and shorter stimulation, with the introduction of the gonadotropin-releasing hormone (GnRH) antagonist protocol, and towards fewer embryos transferred altogether: factors that may influence the outcome positively.
Since the introduction of ART, the postponement of childbearing has also become common worldwide, with more advanced maternal and paternal ages at the birth of the first child. The population of infertility has also changed over time. In the past, the consequence of long waiting times was that reproductive diseases developed to more severe stages, leaving the couple with a more advanced disease and with a poorer prognosis at the start of treatment. As the access to ART treatments has improved, we are now treating couples with shorter durations of infertility and less severe reproductive diseases.
Global ART surveillance data have revealed that ICSI is the preferred fertilisation method in many countries, although the primary indications for ICSI are severe male factor infertility or fertilisation failure in a previous IVF attempt. 1 By this (over)use of ICSI, we are introducing the selection of semen cells and manipulation with the oocyte and sperm in many cases without any medical reason. ICSI has been shown to cause more chromosomal anomalies and in some studies more birth defects. 4, 5 A recent study has shown that severe male factor infertility impairs the fertilisation rate and the embryo developmental potential. The euploidy rate and the implantation potential of the obtained blastocysts, as well as the live birth rates, were independent of sperm quality, however. 6 It remains to be determined to what extent the observed adverse outcomes after ICSI are related to parental factors or are associated with the ICSI procedure itself.
The authority bodies for ART should recommend that ICSI only be applied on strict medical indications, such as severe male factor infertility or fertilisation failure, because of concerns regarding safety aspects.
ART and multiple births
A decade ago, ART multiple birth rates beyond 30% were more the rule than the exception, and nearly half of the children conceived by ART were conceived in twin or higher-order gestations. The single embryo transfer policy has caused a dramatic drop in ART twin birth rates and a simultaneous drop in preterm birth and perinatal mortality rates, especially in countries implementing single embryo transfer policies. 7 Obstetric risks in twin pregnancies are up to 10-fold higher, and even stillbirth rates are doubled compared with singleton pregnancies. 8 Furthermore, the risk of cerebral palsy was significantly higher in twins conceived by ART than that of singletons conceived by ART. 9 By adjusting for preterm birth, the risk of cerebral palsy in ART twins diminished; however, preterm birth should be considered as a mediator and not a confounding factor on the causal pathway of ART twins and neurodevelopmental outcomes. 9 Although the UK, the Netherlands, Belgium, and the Nordic countries have successfully reduced multiple births after ART, the rest of Europe, China, and the USA have made little progress on reducing multiple pregnancies.
Short-term health outcomes of children conceived by ART
Surveillance data for ART can be used to monitor shortand long-term morbidity and mortality in children conceived by ART. 10 In the UK, national ART surveillance data from the Human Fertilisation and Embryology Authority (HFEA) have shown that the risk of preterm birth and low birthweight is higher after fresh embryo transfer if more than 20 oocytes are aspirated in ART cycles. 11 Singletons conceived by ART have a 1.5-to 2.0-fold higher risk of preterm birth and low birthweight, whereas this is not observed in singletons born after frozen embryo transfer (FET). 12 Singletons conceived by FET are more likely to be associated with large-for-gestational-age when compared with spontaneously conceived children, however. 13, 14 In the meta-analysis by Hansen and co-workers, a 32% increased risk of birth defects in children conceived by ART, compared with spontaneously conceived infants was reported; When the criteria were restricted to major birth defects only, the increased risk was 42%. 15 This equates to an absolute risk of 6.5-7.0% in an ART population, with a background birth defect prevalence of 5.0%.
Some countries also include information on specified ART techniques in their ART surveillance data, which provide a unique opportunity to monitor the safety aspects for short-and long-term health outcomes in the children. Blastocyst transfer was included in the Swedish quality IVF registry (Q-IVF) since the register was initiated in 2007. Based on these data, they showed that perinatal mortality and perinatal complications were higher after blastocyst transfer; however, there seemed to be no increased risk of birth defects, which was the major concern. 16 In a cohort study, and subsequent meta-analysis, no association was found between 89 pregnancies conceived after pre-implantation genetic diagnosis (PGD) and risks of adverse neonatal or obstetrical outcomes, compared with 166 ICSI pregnancies. Hence, blastomere biopsy for PGD does not seem to increase the risk for adverse perinatal outcome compared with ICSI pregnancies in these limited data sets. 17 
Long-term health outcomes of children conceived by ART
A study based on HFEA data in the UK showed that there was no increased risk of cancer in children conceived by ART. 18 In this study, the authors used a cross-linkage of obstetric outcomes of the HFEA data and the medical birth and cancer registry to identify children conceived by ART who had a cancer diagnosis. 18 Thus, ART surveillance data are also useful regarding long-term morbidity, if ART and birth data can be coupled with other healthcare registries.
The first study on reproductive health in children conceived by ICSI showed that among 54 young adult men conceived by ICSI as a result of severe male infertility, the median sperm concentration, total sperm count, and total motile sperm count were significantly lower than in spontaneously conceived children, even after adjusting for relevant confounding factors. The men conceived by ICSI were almost three times more likely to have sperm concentrations of <15 million/ml, and were four times more likely to have a total sperm count of <39 million. 19 Antral follicle count and reproductive hormones in a cohort of 71 young adult women conceived by ICSI because of male factor infertility were similar to those reported for women who were spontaneously conceived. 20 In general, the long-term mental and emotional health outcomes, including school performance, for children born from ART are reassuring, and are very similar to those of spontaneously conceived children. 21, 22 A systematic review and meta-analysis reported cardiovascular and metabolic profiles in offspring conceived by ART, and it showed slightly higher blood pressure and altered cardiovascular function. 23 These findings are based on very small studies and need to be confirmed in larger controlled cohort studies. If there is an altered risk profile in children conceived by ART, this may be because of altered epigenetic profiles caused by changes in the very early embryonic phases. The embryo is cultured in vitro from days 2 to 5, at a developmental stage that is very vulnerable to epigenetic changes. This may cause the large-for-gestational-age effect in children conceived after the freezing and thawing of embryos. Epigenetic profiling in children conceived by ART needs further investigation. Few small studies have explored long-term health after PGT-a. In a cohort study on neurodevelopmental outcome, no difference was found in 59 children born after PGT-a and 85 children conceived by conventional IVF. 24 Surveillance of children conceived by ART Surveillance data for ART can be used to study the effectiveness but also the safety of various ART methods, if cross-linkage to data on child morbidity is possible. In the UK, the HFEA has been used for cross-linking ART data with information on childhood cancers. 18 In South Australia, Davies et al. 5 have used ART surveillance data to explore malformation risk in children conceived by ART. In the Nordic countries, the compulsory recording of all ART cycles in IVF registries was initiated in Sweden in 1982 and in the other Nordic countries since the beginning of the 1990s. It has created a unique possibility to explore short-and long-term outcomes in children born after ART. 10 The Committee of Nordic ART and Safety (CoNARTaS) was established in the Nordic countries in 2008 to survey the health of children conceived by ART. 10 Four Nordic countries (Sweden, Denmark, Norway, and Finland) contribute data to the common data platform, consisting of 150 000 children conceived by ART and the complete background populations of singletons and twins in the four Nordic countries. The backbone for the CoNARTaS database is that all Nordic citizens are provided with a unique personal identification number (PIN) immediately after birth. Further ART registries have been established in all Nordic countries with compulsory records of all ART cycles performed, in which the key variable is the female PIN code. Thus, all treatments resulting in birth can be coupled to the medical birth registry to identify all children conceived by ART, and the linkage between ART treatment, mother, and child can be identified.
The national health registries can provide data on diagnoses and drug prescription, and these data can be merged with the data for mothers and children conceived with ART. The following healthcare registries are well established in most Nordic countries: medical birth, hospital and outpatient, drug prescription, cancer, causes of death, diabetes, and socio-economic registries. Further National clinical quality databases can provide national data on specific diseases such as childhood diabetes and epilepsy. It gives a unique opportunity to explore the long-term health of children conceived by ART. By having cycle-based registration and by adding information to the ART registries on specific ART procedures at a very early stage after implementation, we can gain valuable knowledge on the safety aspects of the new ART methods.
Conclusion
The most important health risk in children conceived by ART is still twin conception; thus, the global focus should be on reducing twin birth rates by implementing single embryo transfer in ART. Even ART singletons are more likely to have adverse perinatal outcomes, partly explained by parental factors and partly by the ART itself. Although these factors can be separated through statistical models, we should acknowledge that it may be difficult to separate the two in observational data.
Only large population-based studies on children conceived by ART including specific information on ARTs can survey the safety of new ARTs regarding short-and longterm morbidity. Building up national ART registries requires political and financial support, but is of utmost importance for surveillance of new ARTs and for abandoning unsafe techniques.
The increased use of ART will influence the health of the future generations; hence, continued global efforts to expand ART surveillance will benefit the diverse population of women and men who are attempting to build their families by using ART. The increased use of ICSI, embryo culture media, and new ART methods are areas that need special attention. The key message is that the health of children conceived by ART seems to be reassuring when single embryo transfer is performed; however, the cardiovascular health of these children needs further investigation. To survey short-and long-term adverse effects of the rapidly emerging new technologies in ART, we should not only use rigorous testing before introducing them into routine practice, but also long-term follow-up through the setting up of national and international registries based on the model of CoNARTaS.
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